Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024

April 25, 2024 at 7:00 AM EDT

Company to Host Conference Call to Discuss Results at 8:00 a.m. ET on May 14, 2024

NASHVILLE, Tenn.--(BUSINESS WIRE)--Apr. 25, 2024-- Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Tuesday, May 14, 2024, to discuss the results and provide a business update.

Conference Call Details:  




Tuesday, May 14, 2024



8:00 a.m. Eastern time

Participant Dial-in:


1-833-953-2434 (U.S.)
1-412-317-5763 (International)

Replay Dial-in (Passcode 3093849):

(telephonic replay through May 21, 2024)


1-877-344-7529 (U.S.)
1-412-317-0088 (International)

Webcast: (online replay through May 14, 2025)



About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

Jamie Webb
Director of Communications and Investor Relations

Source: Harrow, Inc.